The French Competition Authority approves a merger between two biomedical laboratories subject to commitments to not acquire any further interest in a particular region for the proceeding decade (Bio Pôle Antilles / Inovie)

Medical pathology laboratories: the Autorité clears, subject to conditions, the takeover of the company Bio Pôle Antilles by the Inovie group For the first time, the Autorité de la concurrence considers that a non-controlling minority stake concomitant with an exclusive takeover is likely to harm competition. Parties to the transaction The Inovie group is mainly active in the medical biology sector and operates a network of more than 400 laboratories located mainly in the southern half of France, in Île-de-France region and La Reunion. Bio Pôle Antilles is also active in the medical biology sector through 14 laboratories,

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

French Competition Authority, The French Competition Authority approves a merger between two biomedical laboratories subject to commitments to not acquire any further interest in a particular region for the proceeding decade (Bio Pôle Antilles / Inovie), 27 April 2022, e-Competitions June 2022 - II, Art. N° 106519

Visites 196

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues